» Articles » PMID: 17381549

Telomere Restoration and Extension of Proliferative Lifespan in Dyskeratosis Congenita Fibroblasts

Overview
Journal Aging Cell
Specialties Cell Biology
Geriatrics
Date 2007 Mar 27
PMID 17381549
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Dyskeratosis congenita (DC), an inherited bone marrow failure syndrome, is caused by defects in telomerase. Somatic cells from DC patients have shortened telomeres and clinical symptoms are most pronounced in organs with a high cell turnover, including those involved in hematopoiesis and skin function. We previously identified an autosomal dominant (AD) form of DC that is caused by mutations in the telomerase RNA component (TER). In this study, we evaluated whether retroviral expression of TER and/or telomerase reverse transcriptase (TERT), the catalytic component of telomerase, could extend telomere length and rescue AD DC cells from a phenotype characteristic of early senescence. Exogenous TER expression, without TERT, could not activate telomerase in AD DC skin fibroblasts. Transduction of TERT alone, however, provided AD DC cells with sufficient telomerase activity to extend average telomere length and proliferative capacity. Interestingly, we found that expression of TER and TERT together resulted in extension of lifespan and higher levels of telomerase and longer telomeres than expression of TERT alone in both AD DC and normal cells. Our results provide evidence that AD DC cells can be rescued from defects in telomere maintenance and proliferation, and that coexpression of TERT and TER together provides a more efficient means to elongate telomeres than expression of TERT alone. Similar strategies may be useful for ameliorating the detrimental effects of telomere shortening in AD DC and other diseases associated with telomerase or telomere defects.

Citing Articles

Fibroblast-Adipocyte Lineage Cell Interactions Result in Differential Production of Extracellular Matrix Proteins.

Sander E, El-Hattab M, Jacobson K, Klingelhutz A, Ankrum J, Calve S Cell Mol Bioeng. 2025; 17(6):597-608.

PMID: 39926384 PMC: 11799492. DOI: 10.1007/s12195-024-00829-8.


Multiple cell types support productive infection and dynamic translocation of infectious Ebola virus to the surface of human skin.

Messingham K, Richards P, Fleck A, Patel R, Djurkovic M, Elliff J Sci Adv. 2025; 11(1):eadr6140.

PMID: 39742475 PMC: 11691639. DOI: 10.1126/sciadv.adr6140.


Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases.

Yang B, Lin Y, Huang Y, Shen Y, Chen Q Redox Biol. 2024; 70:103032.

PMID: 38232457 PMC: 10827563. DOI: 10.1016/j.redox.2024.103032.


CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response.

Westin E, Khodadadi-Jamayran A, Pham L, Tung M, Goldman F G3 (Bethesda). 2023; 13(11).

PMID: 37717172 PMC: 10627266. DOI: 10.1093/g3journal/jkad207.


Effect of gait training using rhythmic auditory stimulation on gait speed in older adults admitted to convalescent rehabilitation wards: A study protocol for a pilot randomized controlled clinical trial.

Igusa T, Kobayashi T, Uchida H, Tsuchiya K, Akiba T, Sema S Contemp Clin Trials Commun. 2023; 33:101125.

PMID: 37091510 PMC: 10119504. DOI: 10.1016/j.conctc.2023.101125.


References
1.
Wang J, Warner J, Erdmann N, Lansdorp P, Harrington L, Dick J . Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells. Proc Natl Acad Sci U S A. 2005; 102(40):14398-403. PMC: 1242297. DOI: 10.1073/pnas.0504161102. View

2.
Armanios M, Chen J, Chang Y, Brodsky R, Hawkins A, Griffin C . Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A. 2005; 102(44):15960-4. PMC: 1276104. DOI: 10.1073/pnas.0508124102. View

3.
Goldman F, Bouarich R, Kulkarni S, Freeman S, Du H, Harrington L . The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A. 2005; 102(47):17119-24. PMC: 1287981. DOI: 10.1073/pnas.0505318102. View

4.
Hao L, Armanios M, Strong M, Karim B, Feldser D, Huso D . Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell. 2005; 123(6):1121-31. DOI: 10.1016/j.cell.2005.11.020. View

5.
Cristofari G, Lingner J . Telomere length homeostasis requires that telomerase levels are limiting. EMBO J. 2006; 25(3):565-74. PMC: 1383536. DOI: 10.1038/sj.emboj.7600952. View